Such great timing.
In what world does the FDA reject Ryoncil for AGVHD but approve Rem-L for COVID ARDS?
I suppose it's possible, of course, but seriously, that would be the FDA shredding the little credibility it has left after this year's various COVID-related debacles.
FDA ODAC Meeting Material discussion analysis, page-345
-
- There are more pages in this discussion • 147 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
0.013(1.07%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.20 | $1.15 | $1.336M | 1.141M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 5615 | $1.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 62470 | 9 |
View Market Depth
| Last trade - 11.03am 16/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |